Invasive Breast Cancer
📧 Sign up to get email alerts when something new happens for Invasive Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Testing MK-3475 (Pembrolizumab) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer [Phase 3]
This is an update on a Phase 3 trial evaluating pembrolizumab (Keytruda) as adjuvant therapy for triple-negative breast cancer, with the stu…
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: Temporal Immunologic Changes With Hypofractionated Radiation-Induced DNA Damage in Breast Cancer
Ongoing MD Anderson trial investigating temporal immunologic changes following hypofractionated radiation-induced DNA damage in breast cance…
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: Individual Factors Associated With Care Pathways Delays in Breast Cancer in Hauts-de-France.
Clinical trial investigates factors associated with delays in breast cancer care pathways in Hauts-de-France; the study is not yet recruitin…
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: Hypofractionated Radiation Therapy vs Standard Treatment in Breast Cancer. [NA]
A clinical trial is evaluating hypofractionated radiation therapy versus standard treatment for breast cancer and is currently active but no…
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: Clinical Information and Biospecimen Collection From Patients With Recurrent or Stage IV Breast Cancer
A clinical trial update indicates that the Mayo Clinic study on clinical information and biospecimen collection from patients with recurrent…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-03-13Clinical Trial Update: Hypofractionated Regional Nodal Irradiation Clinical Trial for Women With Breast Cancer [NA]
The document provides an update on a clinical trial evaluating hypofractionated regional nodal irradiation for women with breast cancer, wit…
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: NearWave Optical Molecular Monitoring [NA]
A recruiting clinical trial from Indiana University evaluating NearWave Optical Molecular Monitoring for breast cancer, including HER2-posit…
-
CLINICAL_TRIALS research · 2026-02-12Clinical Trial Update: AVI Didactic Experience for Latinx Patient Treatment Adherence and Non-English Speaker Trial Enrollment Study in Rad Onc [NA]
Columbia University is conducting a radiation oncology trial to study Latinx patient treatment adherence and enrollment of non-English speak…
-
CLINICAL_TRIALS research · 2026-02-09Clinical Trial Update: CONFIRM: Magnetic Resonance Guided Radiation Therapy [NA]
ClinicalTrials.gov study CONFIRM is evaluating magnetic resonance guided radiation therapy and is currently recruiting for several cancers, …
-
CLINICAL_TRIALS research · 2026-01-23Clinical Trial Update: Pre-operative SABR With and Without Caloric Restriction for Early Stage Breast Cancer [NA]
This clinical trial investigates pre-operative stereotactic ablative radiotherapy (SABR) with or without caloric restriction for early-stage…
-
CLINICAL_TRIALS research · 2026-01-20Clinical Trial Update: Gene Signatures to Guide HR+MBC Therapy in a Diverse Cohort [Phase 2]
Phase 2 clinical trial update evaluating gene signatures to guide therapy for HR-positive metastatic breast cancer in a diverse cohort; the …
-
CLINICAL_TRIALS research · 2026-01-06Clinical Trial Update: Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in IBC [NA]
A clinical trial from the European Institute of Oncology is evaluating sentinel lymph node biopsy after neoadjuvant chemotherapy in invasive…
-
CLINICAL_TRIALS research · 2025-12-17Clinical Trial Update: Stereotactic Body Radiation Therapy (SBRT) for Invasive Breast Cancer Patients Not Undergoing Definitive Surgery [NA]
This clinical trial status update indicates ongoing stereotactic body radiation therapy (SBRT) for invasive breast cancer in patients not un…
-
CLINICAL_TRIALS research · 2025-12-16Clinical Trial Update: The Association Between Axillary Lymph Node Metastasis Patterns and Breast Cancer Prognosis
This clinical trial investigates how axillary lymph node metastasis patterns relate to prognosis in invasive breast cancer.
-
CLINICAL_TRIALS research · 2025-12-03Clinical Trial Update: Prospective Breast Cancer Biospecimen Collection
A Thomas Jefferson University clinical trial is actively recruiting to prospectively collect breast cancer biospecimens for translational re…
-
CLINICAL_TRIALS research · 2025-12-03Clinical Trial Update: Organoids From Breast Cancer Patients Treated With Neoadjuvant Therapy
A clinical trial update describing organoid models derived from breast cancer patients treated with neoadjuvant therapy; the study is curren…
-
CLINICAL_TRIALS research · 2025-11-18Clinical Trial Update: Continuous or Intermittent Extension of Adjuvant Pyrotinib for Invasive HER2-positive Breast Cancer [Phase 3]
A Phase 3 trial is evaluating continuous or intermittent extension of adjuvant pyrotinib for invasive HER2-positive breast cancer.
-
CLINICAL_TRIALS research · 2025-11-10Clinical Trial Update: Ixabepilone in Treating Participants With Significant Residual Disease of HER2/Neu Negative Invasive Breast Cancer After Systemic Therapy [Phase 2]
Phase 2 clinical trial update evaluating ixabepilone for residual disease in HER2-negative invasive breast cancer after systemic therapy.
-
CLINICAL_TRIALS research · 2025-10-14Clinical Trial Update: Sacituzumab Govitecan In TNBC [Phase 2]
Phase 2 study of Sacituzumab Govitecan in triple-negative breast cancer is currently recruiting.
-
CLINICAL_TRIALS research · 2025-10-09Clinical Trial Update: Topical Afimoxifene in Treating Patients With Breast Cancer Who Have Undergone Radiation Therapy on One Breast [Phase 2]
Phase 2 clinical trial investigating topical afimoxifene for breast cancer patients who have undergone radiation therapy on one breast; curr…
-
CLINICAL_TRIALS research · 2025-09-19Clinical Trial Update: TRUDI: TDXD+Durva in HER2+/Low IBC [Phase 2]
Phase 2 trial TRUDI is evaluating trastuzumab deruxtecan (TDXd) plus durvalumab (Durva) in HER2-positive and HER2-low invasive and inflammat…
-
CLINICAL_TRIALS research · 2025-09-05Clinical Trial Update: Cemiplimab in High-risk or Locally Advanced Luminal and Triple Negative Breast Cancer [Phase 2]
A Phase 2 trial update indicates cemiplimab is being studied in high-risk or locally advanced luminal and triple-negative breast cancer, wit…
-
CLINICAL_TRIALS research · 2025-08-22Clinical Trial Update: ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
Guardant Health's ORACLE trial is currently recruiting to evaluate residual cancer using a liquid biopsy across multiple cancer types.
-
CLINICAL_TRIALS research · 2025-07-31Clinical Trial Update: Prospective, Multicentric Study Evaluating the Surgical Treatment by Mastectomy With Immediate Prosthetic Breast Reconstruction in Patients With Breast Cancer and Receiving Adjuvant Therapy by TomoTherapy +/-Chemotherapy. [Phase 2]
A Phase 2 multicenter trial evaluating mastectomy with immediate prosthetic breast reconstruction in breast cancer patients receiving adjuva…
-
CLINICAL_TRIALS research · 2025-07-01Clinical Trial Update: Metabolic Parameters and Quality of Life in Women on Neo-/Adjuvant Therapy for Breast Cancer [NA]
This entry summarizes an ongoing clinical trial evaluating metabolic parameters and quality of life in women receiving neoadjuvant or adjuva…